CLINICAL_TRIALS
trial_result
· 2022-08-08
Clinical Trial Update: A Study To Evaluate The Efficacy And Safety Of TNX-102 SL In Patients With Fibromyalgia [Phase 3]
Summary
Phase 3 clinical trial evaluating TNX-102 SL for fibromyalgia has completed and results were posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tonix Pharmaceuticals, Inc. | Conditions: Fibromyalgia | Phase 3 | Status: COMPLETED | Results posted: 2022-08-08